drug

Parkinson’s disease progression can be slowed down by experimental diabetes drug. The researchers studied a drug that binds to the peroxisome proliferation-activated receptor gamma (PPARγ) agonist medications, such as GZT drugs, which has been shown to offer protection for nerve cells in animal models of Parkinson’s disease. PPARy regulates how the body uses fats and ...click here to read more

A Pennsylvania-based study has found that drug overdoses are on the rise, with a 14-fold increase seen between 1979 and 2014. The findings are similar to a national trend. In December, the Centers for Disease Control and Prevention (CDC) revealed record high numbers of drug overdoses all across the U.S. Majority of drug overdoses are linked ...click here to read more

A new drug to prevent organ rejection after transplantation may also reduce the risk of early death in kidney transplant recipients. The study examined patients who underwent a kidney transplantation and were given belatacept (brand name: Nulojix). The researchers found that over the course of seven years, 43 percent of patients were less likely to ...click here to read more

Multiple sclerosis patients treated with Tysabri (natalizumab) have a 10 times greater risk of developing a deadly brain virus, according to new findings. The virus – John Cunningham virus (JCV) – is a pathogen that causes a rare and deadly condition known as progressive multifocal leukoencephalopathy (PML). The link between Tysabri and PML is not new. ...click here to read more